Madrigal (MDGL)



Company Description

Madrigal Pharmaceuticals is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease and non-alcoholic steatohepatitis (NASH), diabetes, dyslipidemia and cardiovascular disease.


Company Info

COMPANY ADDRESS

200 Barr Harbor Drive
Suite 400
West Conshohocken, PA 19428
United States

COMPANY EMAIL
info@madrigalpharma.com

COMPANY WEBSITE

View Madrigal Stock Chart


Latest Company News